Shanab Pharma
DEVisit shop ↗
‹ Back to the journal

Marketing ·

Immune system claims in autumn: what manufacturers and pharmacies may say

Using authorised immune system claims correctly: guidance for manufacturers and pharmacies on zinc, vitamin C, vitamin D and on reviewing autumn campaigns.

Shanab Pharma editorial team

Illustrative image for the article “Immune system claims in autumn: what manufacturers and pharmacies may say”

English translation of the German article. It reflects the status at the publication date stated above; later developments may differ.

Shanab Pharma · B2B knowledge for Austria and the EU · As of: 12 October 2026

Authorised health claims relating to the immune system exist for zinc, vitamin C and vitamin D. Companies may only use them if the specific food meets the respective conditions. Such a claim does not permit any promise to prevent colds or other diseases. [1–3]

Autumn is a good time to review product pages and sales materials for the winter business. For food supplements relating to the immune system, a single short sentence often determines the message of an entire campaign: does it describe a normal body function, or does it already promise protection against infections?

For manufacturers, pharmacies and trading partners, a joint review of product data, texts and design is therefore worthwhile. This article shows how you can use authorised claims in a traceable way and develop clear information for your distribution partners from them. The basics of market entry can be found in our guide to distributing food supplements in Austria.

Why online advertising should be reviewed before the autumn campaign

An Austrian control report makes the need for action concrete. On 25 February 2025, AGES published the results of focus campaign A-023-24 on food supplements sold through direct sales and online shops. Of 35 samples examined, 22 were objected to, some on several grounds. Eight objections concerned the Claims Regulation. The impermissible misleading, disease-related or unauthorised health claims were found exclusively on the product-related web pages. [4]

This targeted control does not describe a representative error rate for the market as a whole. It does show, however, that a proper label alone is not enough for a clean online presence.

Our recommendation for the autumn business is therefore: review the product page as it is actually displayed, in addition to the approved text file. This includes the headline, teaser, image captions, FAQ and the ads that lead to the page. Decide in advance who approves changes and how corrected materials reach trading partners.

What an authorised immune system claim states

An example from the EU list reads:

Zinc contributes to the normal function of the immune system.

Its use requires the food to meet the conditions for a source of zinc. Regulation (EU) No 432/2012 also contains corresponding authorised function claims for vitamin C and vitamin D; the requirements relate in each case to the nutrient named. [2]

The link to the nutrient is essential. A claim relating to zinc cannot simply be transferred to an added plant extract or to the entire formulation as independent proof of effect.

The European Commission explains the difference between scientific assessment and authorisation: EFSA assesses the scientific evidence; the Commission decides on authorisation. A single study therefore does not replace a permissible advertising claim. [5]

For practical implementation, a table per article is advisable: nutrient, amount in the intended daily portion, selected claim, specific conditions of use and the documents with which you prove compliance. Have any open questions about quantities or versions resolved before the text goes into the campaign.

Normal function is not a promise against colds

Food information must not attribute to a food the property of preventing, treating or curing a human disease. This requirement also covers advertising and presentation. [3]

A statement about normal immune function must therefore not be extended into a promise against a cold. Nor does an additional note in the small print make a contradictory main message reliable.

The following examples are editorial review aids, not blanket approvals for specific products:

“Prevents colds”

Review point: disease prevention is attributed to the food.

Revision: delete the statement; where appropriate, use a suitable authorised nutrient claim together with its conditions.

“Strengthens your defences instantly”

Review point: “instantly” promises a point in time; “strengthens” may go beyond the authorised claim.

Revision: describe the normal function factually and do not add any speed.

“Immune booster” as a large headline

Review point: it may convey an additional increase in immune performance.

Revision: review the specific message together with the accompanying text; choose a restrained headline and a clear link to the nutrient.

Viruses bouncing off a protective shield in a product image

Review point: the image may convey a promise of protection, even without explicit text.

Revision: use a neutral product or consultation scene.

“With zinc, vitamin C and vitamin D”

Review point: stating the ingredients does not replace the review of every additional health message.

Revision: check composition and health claims separately for accuracy and conditions.

In this way, the benefits of a product remain understandable without making the statement stronger than its basis allows. For distribution, well-prepared product data, a comprehensible daily portion and clear directions for use can also be more valuable than an interchangeable superlative.

General health messages need a clear assignment

Under Article 10(3) of the Claims Regulation, general, non-specific references to benefits for overall health or well-being may only be made if accompanied by a suitable authorised specific health claim. [1]

The Commission’s guidelines recommend placing the specific claim directly next to or below the general reference. The connection should be recognisable to consumers. [6]

For your design, this means: plan the required accompanying text into the layout from the start. Check the mobile view in particular. If the headline is on the first screen and the explanatory claim only appears far below, text and design should be revised together. This recommendation does not replace an assessment of the specific claim, but it prevents a common break between text approval and what is actually displayed.

Plant extracts: check the claim status separately

Formulations containing botanical substances require an additional review. On 30 April 2025, in case C-386/23, Novel Nutriology, the Court of Justice of the European Union confirmed the general prohibition of unauthorised health-related advertising for botanical substances. The Court’s press release expressly refers to possible transitional arrangements. The specific case concerned claims about psychological functions for saffron and melon juice extracts. [7]

This does not mean that every plant-related claim is prohibited in all circumstances. For your campaign, it must rather be clarified which specific claim is to be used and on which legal basis. An open or “on hold” status should not be treated as a general permission to advertise.

In practice, it is advisable to document botanical claims separately. A permissible zinc claim does not answer the question of advertising for an extract that is also contained in the product.

An approval checklist for manufacturers and trading partners

For working together, we recommend a short, reusable process. It is an organisational aid; the specific product and advertising review remains separate.

  1. Record the product version. Use the current formulation, the applicable label and the associated specifications. Record which article and pack variant is being reviewed.
  2. Collect all claims. Capture the product page, ads, social media visuals, leaflets and materials for pharmacies. Short image captions also belong in the overview.
  3. Classify the claims. Distinguish between statements on composition, nutrition claims, health claims and possible disease-related promises. For health claims, note the nutrient or substance to which they refer.
  4. Document the conditions. Check the current register entry and the underlying legislation. Assign the appropriate product document to each claim used. The EU Register contains authorised and non-authorised claims and supports this research. [8]
  5. Check accompanying information. Article 10(2) requires, among other things, information on the importance of a varied and balanced diet and a healthy lifestyle, as well as on the quantity of the food and the pattern of consumption required. Target group information and warnings may also be needed. [1]
  6. Check the finished presentation. Read the desktop and mobile views, check image messages and open the links. Approval of the text document should not be the last check.
  7. Distribute one approved version. Give your partners a package with texts, images and a date. Name a contact person and document when older materials were replaced.

For pharmacies, a concise overview is helpful: what is the product, what amounts does it contain, what is the recommended daily intake and which claims are intended for use? Add clear ordering and delivery information. This makes cooperation easier without overloading product advice with advertising promises.

Frequently asked questions about immune system claims

May a food supplement be advertised with an effect on the immune system?

This is possible with a suitable authorised claim if the specific product meets all the conditions. Corresponding claims are provided for zinc, vitamin C and vitamin D. This does not give permission for any promise against infections. [1–3]

Is it enough to derive the claim from a scientific article?

A scientific publication is not the same as authorisation for advertising. Check the legal status of the intended claim and its conditions. The EFSA assessment and the authorisation by the Commission are different steps. [5]

Does advertising have to be reviewed even if the label has already been checked?

Yes. The product page, ad and visual design can convey additional messages. The Austrian AGES report of 25 February 2025 documents objections to impermissible claims on product websites. [3, 4]

Is “immune booster” automatically a permissible substitute for a function claim?

Such wording is not an automatically approved substitute. What matters is the message, context and accompanying text. For approval, a specific review is advisable rather than a general list of words. [1, 6]

Does the same approval apply to plant extracts as to the vitamins contained?

The claims must be reviewed separately. A vitamin claim does not automatically cover a plant extract. For botanical claims, the authorisation status and any applicable transitional rules in particular must be clarified. [2, 7]

Preparing autumn campaigns together

Shanab Pharma supports manufacturers with logistics, distribution and marketing and works with pharmacies and companies. Find out more about our services.

Are you planning an autumn or winter range for the Austrian pharmacy market? Put together your current product documents, intended distribution channels and campaign drafts. Contact Shanab Pharma to discuss your support needs and the next steps.

Sources and legal basis

All linked primary sources were researched on 12 October 2026. The organisational processes and design examples in this article are editorial recommendations.

  1. Regulation (EC) No 1924/2006: in particular Article 10, consolidated version of 13 December 2014.
  2. Regulation (EU) No 432/2012: authorised function claims and conditions, consolidated version of 20 August 2025.
  3. Regulation (EU) No 1169/2011: in particular Article 7, consolidated version of 1 April 2025.
  4. AGES: Food supplements from direct sales and online shops, focus campaign A-023-24, published on 25 February 2025 (in German).
  5. European Commission: Health claims – assessment and authorisation.
  6. Implementing Decision 2013/63/EU of 24 January 2013: guidelines on Article 10.
  7. Court of Justice of the European Union: press release No 57/25 on judgment C-386/23, 30 April 2025 (German version). The press release summarises the judgment and is not itself the binding text of the decision.
  8. European Commission: EU Register of Nutrition and Health Claims.

This article provides general guidance on B2B communication. The assessment of a specific product or advertising visual depends on its composition, daily portion, target group and complete presentation.